EP2170279
Aðferðir til að framleiða arípíprasólsviflausn og frostþurrkaða samsetningu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.7.2008EP published:
27.12.2017EP application number:
08792242.3
EP translation filed:
20.3.2018Grant published:
15.4.2018EPO information:
European Patent Register
Max expiry date:
29.7.2028Expiry date:
29.7.2026Next due date:
31.7.2026
Title:
METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND FREEZE-DRIED FORMULATION
Timeline
Today
30.7.2008EP application
27.12.2017EP Publication
20.3.2018Translation submitted
15.4.2018Registration published
29.7.2026Expires
Owner
Name:
Otsuka Pharmaceutical Co., Ltd.Address:
9, Kanda-Tsukasa-machi 2-chome Chiyoda-ku, 101-8535, Tokyo, JP
Inventor
Name:
HIRAOKA, ShogoAddress:
Osaka-shiOsaka, JP
Name:
MATSUDA, TakakuniAddress:
Osaka-shiOsaka, JP
Name:
HATANAKA, JunichiAddress:
Osaka-shiOsaka, JP
Agent
Name:
LEX ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
2007200088Date:
31.7.2007Country:
JP
Classification
Categories:
A61K 9/10, A61K 9/19, A61K 31/496, A61K 47/38, A61K 47/32
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 7.6.2018
Expires: 29.7.2019
Payer: Árnason Faktor
Number: 12
Paid: 5.6.2019
Expires: 29.7.2020
Payer: Árnason Faktor
Number: 13
Paid: 12.6.2020
Expires: 29.7.2021
Payer: Árnason Faktor ehf.
Number: 14
Paid: 8.6.2021
Expires: 29.7.2022
Payer: Árnason Faktor ehf.
Number: 15
Paid: 9.6.2022
Expires: 29.7.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 11.6.2023
Expires: 29.7.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 7.6.2024
Expires: 29.7.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 9.7.2025
Expires: 29.7.2026
Payer: Árnason Faktor ehf.